Latest Nzx News

AoFrio Limited is offering existing shareholders a 1-for-7 rights issue at NZ$0.07 per share following a NZ$4.56 million placement, aiming to raise nearly NZ$5 million to fund growth ambitions.

Vista Group International has secured a five-year contract to transition Cinemex’s Mexican cinema circuit back to its technology platform, expanding on last year’s US rollout success.

KMD Brands delivered steady sales growth and margin improvement in Q3 FY26, driven by Kathmandu and Rip Curl, while launching a business review to explore options for accelerating shareholder value.

Savor Limited has swung back to profitability in FY26, delivering a net profit after tax of $1.3 million alongside its strongest operating margin ever at 14.5%. The hospitality group also reduced leverage significantly and is set to pay its first dividend, marking a milestone after years of losses.

Millennium & Copthorne Hotels New Zealand (MCK) posted robust 2025 revenue gains driven by acquisitions and refurbishments, yet signals a cautious outlook for 2026 as geopolitical tensions and rising costs cloud the horizon.

CDL Investments reported a 28% drop in 2025 profit amid subdued New Zealand residential property conditions but advanced major projects and secured fast-track consents. The company expects a tougher 2026 with lower earnings due to ongoing economic and geopolitical uncertainties.

Goodman NZ surged to a $248 million statutory profit in FY26, propelled by strong property revaluations and leasing gains, while advancing major development projects and transitioning to a stapled group structure.

New Zealand King Salmon (NZK) reversed prior losses with a $13.8 million net profit in 1HY26, upgrading its full-year earnings outlook and advancing key growth infrastructure.

Ryman Healthcare reported a substantial reduction in net loss for FY26 alongside its first positive free cash flow in over a decade, driven by operational improvements, refinancing, and land divestments.

Fisher & Paykel Healthcare posted a 14% revenue increase to NZ$2.31 billion and a 24% rise in net profit to NZ$468.5 million for FY2026, driven by strong hospital product sales and ongoing innovation.

Infratil posted an 11% rise in operational EBITDAF to NZ$989 million in FY26, fuelled by a record 555MW CDC data centre contract and a 170% EBITDAF jump at Longroad Energy. The company refined its portfolio with over NZ$600 million in divestments and secured a BBB+ credit rating, underpinning a strong FY27 outlook.

Pacific Edge reported a steep 47% revenue drop in FY26 following Medicare coverage loss but secured a draft Medicare policy covering its Cxbladder tests and raised NZ$25.4 million to fuel growth and commercial execution.